NCT06856200
- Conditions
- Advanced HR - Positive, HER2 - Negative Breast Cancer, Resistant to (Neo)Adjuvant Endocrine Therapy
- Locations
-
- Cancer Hospital Affiliated to Fudan University Shanghai, China
Clinical trial condition
Resistant to (Neo)Adjuvant Endocrine Therapy
Explore clinical trials studying Resistant to (Neo)Adjuvant Endocrine Therapy. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study